Associated Papers
A scalable approach to resolving variants of uncertain significance.
Tejura M et al.
Biorxiv : the Preprint Server for Biology, 2026
Epidemiological, Genetic, Clinical, and Treatment Differences of Generalized Pustular Psoriasis and Acrodermatitis Continua of Hallopeau Across Ethnicities: A Systematic Review.
Hsu FL et al.
American Journal of Clinical Dermatology, 2025
IL-36RN gene: key insights into its role in pediatric pustular psoriasis pathogenesis and treatment.
Wang Y et al.
Frontiers in Pediatrics, 2025
Stimulating T cell responses against patient-derived breast cancer cells with neoantigen peptide-loaded peripheral blood mononuclear cells.
Sueangoen N et al.
Cancer Immunology, Immunotherapy : Cii, 2024
IL36RN Mutations and Correlated Characteristics in Generalized Pustular Psoriasis Patients in Can Tho City, Vietnam: A Cross-Sectional Study.
Nguyen Thi Thuy T et al.
Dermatology (basel, Switzerland), 2024
Case report: Successful treatment with spesolimab of acrodermatitis continua of Hallopeau in an older patient without IL36RN mutations.
Zheng J et al.
Frontiers in Immunology, 2024
In Silico and In Vitro Analysis of IL36RN Alterations Reveals Critical Residues for the Function of the Interleukin-36 Receptor Complex.
Hassi NK et al.
The Journal of Investigative Dermatology, 2023
A viewpoint on the genetic determinants of generalised pustular psoriasis.
Capon F
Experimental Dermatology, 2023
An update on genetic basis of generalized pustular psoriasis (Review).
Zhou J et al.
International Journal of Molecular Medicine, 2021
Association between mutation of interleukin 36 receptor antagonist and generalized pustular psoriasis: A PRISMA-compliant systematic review and meta-analysis.
Liu ZJ et al.
Medicine, 2020
Myeloperoxidase Modulates Inflammation in Generalized Pustular Psoriasis and Additional Rare Pustular Skin Diseases.
Haskamp S et al.
American Journal of Human Genetics, 2020
Clinical and genetic differences between pustular psoriasis subtypes.
Twelves S et al.
The Journal of Allergy and Clinical Immunology, 2019
Codeine-induced acute generalized exanthematous pustulosis without IL36RN mutations.
Chadli Z et al.
Pharmacogenomics, 2018
The genetic basis for most patients with pustular skin disease remains elusive.
Mössner R et al.
The British Journal of Dermatology, 2018
Clinical profiles of pediatric patients with GPP alone and with different IL36RN genotypes.
Wang Y et al.
Journal of Dermatological Science, 2017
IL36RN Mutations Affect Protein Expression and Function: A Basis for Genotype-Phenotype Correlation in Pustular Diseases.
Tauber M et al.
The Journal of Investigative Dermatology, 2016
IL36RN gene analysis of two Japanese patients with generalized pustular psoriasis.
Shiratori T et al.
International Journal of Dermatology, 2015
The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.
Sugiura K
Journal of Dermatological Science, 2014
Novel IL36RN mutation in a Japanese case of early onset generalized pustular psoriasis.
Kanazawa N et al.
The Journal of Dermatology, 2013
Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes.
Setta-Kaffetzi N et al.
The Journal of Investigative Dermatology, 2013
Correlation of IL36RN and CARD14 mutations with clinical manifestations and laboratory findings in patients with generalised pustular psoriasis.
Trai NN et al.
Indian Journal of Dermatology, Venereology and Leprology, 0